Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-oncology: From Basic Research to Advanced Study
Editat de Imteyaz Qamar, Pawan Kumar Mauryaen Limba Engleză Paperback – 31 mai 2022
Anti-cancer treatment is associated with serious cardiovascular adverse events, including arterial and pulmonary hypertension, supraventricular and ventricular arrhythmias, systolic and diastolic cardiac dysfunction and coronary artery disease. Progress in cancer therapy over the past decades improved long-term survival but increased cancer therapy-related cardiotoxicity. Both traditional chemotherapeutic agents and newer therapies have demonstrated profound cardiovascular toxicities. It is important to understand the mechanisms of these toxicities to establish strategies for the prevention and management of complications—arrhythmias, heart failure, and even death.
- Adopts a translational approach and comprehensively covers the basic science, mechanisms and concepts of cardio-oncology
- Outlines the current knowledge of biomarkers in cancer therapy-related cardiotoxicity
- Provides an understanding of the mechanisms of cardiovascular toxicity of various therapies that may lead to the identification of novel targets to reduce vascular complications
Preț: 734.04 lei
Preț vechi: 967.64 lei
-24% Nou
Puncte Express: 1101
Preț estimativ în valută:
140.49€ • 146.43$ • 116.95£
140.49€ • 146.43$ • 116.95£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323904612
ISBN-10: 0323904610
Pagini: 276
Ilustrații: 35 illustrations (20 in full color)
Dimensiuni: 152 x 229 x 23 mm
Greutate: 0.44 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0323904610
Pagini: 276
Ilustrații: 35 illustrations (20 in full color)
Dimensiuni: 152 x 229 x 23 mm
Greutate: 0.44 kg
Editura: ELSEVIER SCIENCE
Cuprins
1. Preface
2. Overview of changes in the Cardiovascular system
3. Cardiovascular Disease in cancer survivors: Risk and management
4. Recent trends in Cancer Immunotherapy: Pathways and inhibitors
5. Stroke risk assessment and Atrial fibrillation in cancer patients
6. Biochemistry of Biomarkers in Cardiotoxicity induced by chemotherapeutic drugs
7. Cardio-toxic effects of Tyrosine kinase inhibitors directed against VEGFR
8. Critical insights into Cardiotoxicity of Anthracyclines
9. Noninvasive Cardiovascular imaging techniques
10. Radiotherapy induced( RIDH) Cardiovascular risk
11. Cardiovascular complication from cancer therapy
12. Novel Anticancer drugs related to Cardiotoxicity
13. Principles of cardiovascular rehabilitation
14. Hematopoietic stem cell transplantation
2. Overview of changes in the Cardiovascular system
3. Cardiovascular Disease in cancer survivors: Risk and management
4. Recent trends in Cancer Immunotherapy: Pathways and inhibitors
5. Stroke risk assessment and Atrial fibrillation in cancer patients
6. Biochemistry of Biomarkers in Cardiotoxicity induced by chemotherapeutic drugs
7. Cardio-toxic effects of Tyrosine kinase inhibitors directed against VEGFR
8. Critical insights into Cardiotoxicity of Anthracyclines
9. Noninvasive Cardiovascular imaging techniques
10. Radiotherapy induced( RIDH) Cardiovascular risk
11. Cardiovascular complication from cancer therapy
12. Novel Anticancer drugs related to Cardiotoxicity
13. Principles of cardiovascular rehabilitation
14. Hematopoietic stem cell transplantation